Capricor Therapeutics
CAPR
CAPR
120 hedge funds and large institutions have $174M invested in Capricor Therapeutics in 2025 Q1 according to their latest regulatory filings, with 32 funds opening new positions, 46 increasing their positions, 25 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
2% more ownership
Funds ownership: 38.11% → 40.11% (+2%)
27% less capital invested
Capital invested by funds: $239M → $174M (-$65.2M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
120
Holding in Top 10
–
Calls
$17M
Puts
$11.6M
Top Buyers
| 1 | +$3.36M | |
| 2 | +$2.57M | |
| 3 | +$2.27M | |
| 4 |
SCM
Superstring Capital Management
New York
|
+$1.76M |
| 5 |
Morgan Stanley
New York
|
+$1.74M |
Top Sellers
| 1 | -$9.85M | |
| 2 | -$3.47M | |
| 3 | -$2.07M | |
| 4 |
UOC
UBS O'Connor
Chicago,
Illinois
|
-$1.45M |
| 5 |
Jane Street
New York
|
-$1.43M |